Ovarian hyperstimulation syndrome: An endocrinopathy?

Current Opinion in Obstetrics and Gynecology

Volumn 13, Issue 3, 2001, Pages 329-333

  Mathur, Raj ^a   Jenkins, Julian ^b  

^a Rosie Maternity Hospital   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; VASCULOTROPIN;

CLINICAL FEATURE; HUMAN; LIVER FUNCTION; OSMOREGULATION; OVARY HYPERSTIMULATION; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN INTERACTION; REVIEW;

FEMALE; HUMANS; OVARIAN HYPERSTIMULATION SYNDROME;

EID: 0034923665     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-200106000-00014     Document Type: Review

References (32)

1. The ovarian hyperstimulation syndrome
2. Role of vascular endothelial growth factor in ovarian physiology and pathology
3. The role of luteal phase support in infertility treatment: A meta-analysis of randomized trials
4. Distinction between early and late ovarian hyperstimulation syndrome
5. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome
6. Role of vascular endothelial growth factor in ovarian hyperstimulation syndrome
7. The kallikrein-kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndrome
8. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome
9. Serum concentrations of vascular endothelial growth factor cannot predict the course of severe ovarian hyperstimulation
10. Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome
11. Changes in serum vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in vitro fertilization programme
12. Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration
13. Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: A preliminary report
14. Value of serum and follicular fluid cytokine profile in the prediction of moderate to severe ovarian hyperstimulation syndrome
15. Serum vascular endothelial growth factor and ovarian stromal blood flow are increased in women with polycystic ovaries
16. Interleukin-8 expression and modulation in human preovulatory follicles and ovarian cells
17. Immunohistochemical evidence for the presence of tumor necrosis factor-alpha in the infant and human ovary
18. Expression of interleukin-6 and interleukin-6 receptors in human granulosa lutein cells
19. Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis
20. Interleukin-8 as macrophage-derived mediator of angiogenesis
21. Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers
22. Correlation of serum cytokine and acute phase reactant levels with alterations in weight and serum albumin in patients receiving immunotherapy with recombinant IL-2
23. Increased vascular permeability in organs mediated by the systemic administration of lymphokine-activated cells and recombinant interleukin-2 in mice
24. Elevated concentrations of interleukin-6 in the follicular fluid at the time of oocyte retrieval for in vitro fertilization may predict the development of early-form ovarian hyperstimulation syndrome
25. Characterisation of intraperitoneal cytokines and nitrites in women with severe ovarian hyperstimulation syndrome
26. Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome
27. A case of spontaneous ovarian hyperstimulation syndrome with a potential mutation in the hCG/LH receptor gene
28. Tumour necrosis factor-alpha (TNF-α) gene polymorphism and expression in pre-eclampsia
29. Coexistent haemoconcentration and hypo-osmolality during superovulation and in severe ovarian hyperstimulation syndrome: A volume homeostasis paradox
30. Relationships of serum pro-inflammatory cytokines and vascular endothelial growth factor with liver dysfunction in severe ovarian hyperstimulation syndrome
31. Unpredictable cases of complicated ovarian hyperstimulation following IVF
32. The significance of the number of antral follicles prior to stimulation in predicting the ovarian responses in an IVF programme